These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21128685)

  • 1. A structural study of norovirus 3C protease specificity: binding of a designed active site-directed peptide inhibitor.
    Hussey RJ; Coates L; Gill RS; Erskine PT; Coker SF; Mitchell E; Cooper JB; Wood S; Broadbridge R; Clarke IN; Lambden PR; Shoolingin-Jordan PM
    Biochemistry; 2011 Jan; 50(2):240-9. PubMed ID: 21128685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses.
    Kim Y; Lovell S; Tiew KC; Mandadapu SR; Alliston KR; Battaile KP; Groutas WC; Chang KO
    J Virol; 2012 Nov; 86(21):11754-62. PubMed ID: 22915796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-guided design and optimization of dipeptidyl inhibitors of norovirus 3CL protease. Structure-activity relationships and biochemical, X-ray crystallographic, cell-based, and in vivo studies.
    Galasiti Kankanamalage AC; Kim Y; Weerawarna PM; Uy RA; Damalanka VC; Mandadapu SR; Alliston KR; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC
    J Med Chem; 2015 Apr; 58(7):3144-55. PubMed ID: 25761614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and inhibitor studies of norovirus 3C-like proteases.
    Takahashi D; Kim Y; Lovell S; Prakash O; Groutas WC; Chang KO
    Virus Res; 2013 Dec; 178(2):437-44. PubMed ID: 24055466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into cleavage specificity from the crystal structure of foot-and-mouth disease virus 3C protease complexed with a peptide substrate.
    Zunszain PA; Knox SR; Sweeney TR; Yang J; Roqué-Rosell N; Belsham GJ; Leatherbarrow RJ; Curry S
    J Mol Biol; 2010 Jan; 395(2):375-89. PubMed ID: 19883658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization and preliminary X-ray diffraction analysis of the protease from Southampton norovirus complexed with a Michael acceptor inhibitor.
    Hussey RJ; Coates L; Gill RS; Wright JN; Sarwar M; Coker S; Erskine PT; Cooper JB; Wood S; Clarke IN; Lambden PR; Broadbridge R; Shoolingin-Jordan PM
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Nov; 66(Pt 11):1544-8. PubMed ID: 21045318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of active-site amino acid residues in the Chiba virus 3C-like protease.
    Someya Y; Takeda N; Miyamura T
    J Virol; 2002 Jun; 76(12):5949-58. PubMed ID: 12021327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design and functional studies of novel noroviral 3C protease chimaeras offer insights into substrate specificity.
    Herod MR; Prince CA; Skilton RJ; Ward VK; Cooper JB; Clarke IN
    Biochem J; 2014 Dec; 464(3):461-72. PubMed ID: 25275273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and evaluation of a novel series of macrocyclic inhibitors of norovirus 3CL protease.
    Damalanka VC; Kim Y; Galasiti Kankanamalage AC; Lushington GH; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC
    Eur J Med Chem; 2017 Feb; 127():41-61. PubMed ID: 28038326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A norovirus protease structure provides insights into active and substrate binding site integrity.
    Nakamura K; Someya Y; Kumasaka T; Ueno G; Yamamoto M; Sato T; Takeda N; Miyamura T; Tanaka N
    J Virol; 2005 Nov; 79(21):13685-93. PubMed ID: 16227288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putative structural rearrangements associated with the interaction of macrocyclic inhibitors with norovirus 3CL protease.
    Galasiti Kankanamalage AC; Weerawarna PM; Rathnayake AD; Kim Y; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC
    Proteins; 2019 Jul; 87(7):579-587. PubMed ID: 30883881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-guided design, synthesis and evaluation of oxazolidinone-based inhibitors of norovirus 3CL protease.
    Damalanka VC; Kim Y; Galasiti Kankanamalage AC; Rathnayake AD; Mehzabeen N; Battaile KP; Lovell S; Nguyen HN; Lushington GH; Chang KO; Groutas WC
    Eur J Med Chem; 2018 Jan; 143():881-890. PubMed ID: 29227928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus.
    Goetz DH; Choe Y; Hansell E; Chen YT; McDowell M; Jonsson CB; Roush WR; McKerrow J; Craik CS
    Biochemistry; 2007 Jul; 46(30):8744-52. PubMed ID: 17605471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study.
    Ang MJ; Lau QY; Ng FM; Then SW; Poulsen A; Cheong YK; Ngoh ZX; Tan YW; Peng J; Keller TH; Hill J; Chu JJ; Chia CS
    J Enzyme Inhib Med Chem; 2016; 31(2):332-9. PubMed ID: 25792507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors.
    Chang KO; Kim Y; Lovell S; Rathnayake AD; Groutas WC
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30823509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.
    Lai L; Han X; Chen H; Wei P; Huang C; Liu S; Fan K; Zhou L; Liu Z; Pei J; Liu Y
    Curr Pharm Des; 2006; 12(35):4555-64. PubMed ID: 17168761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced simulations and screening to repurposing a 3C protease inhibitor against the rupintrivir-resistant human norovirus-induced gastroenteritis.
    Behmard E; Ghasemian A; Barzegari E; Farjadfar A; Kouhpayeh A; Najafipour S
    J Mol Graph Model; 2023 Jan; 118():108345. PubMed ID: 36308946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease.
    Damalanka VC; Kim Y; Alliston KR; Weerawarna PM; Galasiti Kankanamalage AC; Lushington GH; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC
    J Med Chem; 2016 Mar; 59(5):1899-913. PubMed ID: 26823007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and Antiviral Studies of the Human Norovirus GII.4 Protease.
    Muzzarelli KM; Kuiper B; Spellmon N; Brunzelle J; Hackett J; Amblard F; Zhou S; Liu P; Kovari IA; Yang Z; Schinazi RF; Kovari LC
    Biochemistry; 2019 Feb; 58(7):900-907. PubMed ID: 30605321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norovirus Protease Structure and Antivirals Development.
    Zhao B; Hu L; Song Y; Patil K; Ramani S; Atmar RL; Estes MK; Prasad BVV
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.